Laboratory automation veteran brings nearly three decades of commercial and technical leadership to drive growth of Thomas Scientific's technical sales organization
SWEDESBORO, N.J. — Aug. 20, 2026 — Life Science Newswire – Thomas Scientific, a trusted distributor of laboratory supplies, equipment, and services, today announced that Jeff Hrush has joined the company as Senior Vice President, Technical Sales. Hrush brings nearly three decades of commercial and technical leadership in laboratory automation and life-sciences instrumentation to the role.
"Jeff has an established book of business and long-standing customer relationships in the automation and reference-lab segment, and he's bringing those relationships with him to Thomas Scientific," said Adrian Whipple, Chief Operating Officer and Chief Financial Officer of Thomas Scientific. "He's going to lead our technical sales organization, and what makes him such a strong fit is that he pairs hands-on instrumentation expertise with a proven track record of building and scaling commercial teams across our industry. We're glad to have him on board."
Hrush is the founder of Hrush LLC, a laboratory automation consultancy that designs automation systems, optimizes lab workflows, and develops complete laboratory solutions, built on more than 28 years of industry experience. His career spans both instrument manufacturers and high-growth commercial organizations. He began in technical roles at Tecan — serving as applications engineer, product manager, and sales engineer — before moving into sales leadership at Hamilton Company, where he served as Director of Sales for the Midwest and Southeast and later as National Sales Manager. He went on to hold senior commercial roles as Vice President of Strategic Sales at Diversified Medical Healthcare, Chief Commercial Officer at Grenova (where he also served on the board), and Vice President and Head of Sales and then Chief Sales Officer at Rhinostics.
His areas of expertise include laboratory automation, biotechnology, genomics, and immunoassays. He completed Harvard Business School's Negotiation Mastery program in 2019 and holds a B.S. in Biology from Campbell University.